ClinVar Miner

Submissions for variant NM_004004.6(GJB2):c.176G>A (p.Gly59Asp)

dbSNP: rs104894404
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 1
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine RCV000150733 SCV000198166 likely pathogenic Rare genetic deafness 2014-10-23 criteria provided, single submitter clinical testing The p.Gly59Asp variant in GJB2 has not been reported in individuals with hearing loss or in large population studies. However, several missense variants at the same amino acid position (p.Gly59Ala, p.Gly59Val, p.Gly59Arg, p.Gly59Ser) have b een reported in individuals with sensorineural hearing loss with or without palm oplantar hyperkeratosis. These variants were observed to segregate in affected f amily members in several pedigrees in an autosomal dominant pattern (Heathcote 2 000, Toth 2004, Leonard 2005, Alexandrino 2005), and in one study the variant wa s confirmed to have occurred de novo (Leonard 2005). This information strongly s uggests that variants at this amino acid residue are not tolerated. In addition, computational prediction tools and conservation analysis suggest that the p.Gly 59Asp variant may impact the protein. In summary, although additional studies ar e required to fully establish its clinical significance, this variant is likely pathogenic.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.